Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPURE.L Regulatory News (PURE)

  • There is currently no data for PURE

LTIP Options

10 Jul 2012 07:00

RNS Number : 2708H
PureCircle Limited
10 July 2012
 



PURECIRCLE LIMITED

("PureCircle" or "the Company")

Long Term Incentive Plan (LTIP) Options - New Options Granted and Exercised by Directors

 

PureCircle (LSE: PURE), the world's largest producer and marketer of high purity stevia provides an update of new options granted and options exercised and vested under the Company's LTIP.

The Board of PureCircle had on 10 July 2012 granted options to certain Directors of the Company. These options include:

(1) discretionary LTIP award granted to an Executive Director which shall vest on the third anniversary of the grant at Nil exercise price; and

(2) options granted to certain Non-Executive Directors in lieu of their fees covering 6-month period from 1 July 2012 to 31 December 2012. These options have an exercise price of GBP1.3715 per share (US$2.1343 per share), calculated based on 20 days weighted average closing price prior to 1 July 2012. These options shall vest on 1 January 2013.

Details of the options granted are provided in the table below.

Options previously granted to Non-Executive Directors have been vested and exercised on 10 July 2012 and were satisfied by the Company's Treasury shares at the exercise price of GBP1.15 per share (US$1.84 per share). Total options exercised were 36,600 and details are set out in the table below.

Director

Options Granted on 10 July 2012

Options Exercised on 10 July 2012

Options Outstanding

Mr M Malsagov (Executive)

Nil

Nil

456,000

W Mitchell (Executive)

35,000

Nil

316,000

Mr P Lai (Non-Executive)

11,700

13,550

11,700

Mr O Maes (Non-Executive)

Nil

12,200

Nil

Mr J Slosar (Non-Executive)

9,400

10,850

9,400

Total

56,100

36,600

793,100

Following the above options exercised, total issued ordinary shares is 154,566,294 of which 38,142 are held as treasury shares. The number of voting rights in the Company is 154,528,152. This figure should be used by shareholders as the denominator for the notification of their interest in the Company under the FSA's Disclosure and Transparency Rules.

Application has been made to AIM for the shares released from treasury to be admitted to trading on AIM.

 

For more information:

PureCircle Limited (www.purecircle.com)

Magomet Malsagov, CEO

+60 1 2388 8049

William Mitchell, CFO

 +44 7974 005 163

RFC Ambrian Ltd (NOMAD)

Stephen Allen

+61 8 9480 2500

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCRLMTTMBJMTJT
Date   Source Headline
6th Jul 20157:00 amRNSPRECLOSE PERIOD UPDATE FY 2015
24th Apr 20157:00 amRNSAcquisition of remaining equity interest in PCJX
13th Apr 20157:23 amRNSDealings in Shares
10th Apr 20157:00 amRNSExercise of Options and Movement Treasury Shares
16th Mar 20157:00 amRNSInterim Results
9th Mar 20157:00 amRNSAnnouncement of Interim Results
28th Jan 20157:00 amRNSSustainability Report
27th Jan 20157:00 amRNSNotification of a Major Interest
14th Jan 20157:00 amRNSGrant of Options and Movement of Treasury Shares
5th Jan 20157:00 amRNSTrading Update
4th Dec 20147:00 amRNSResult of AGM
21st Nov 20147:00 amRNSHolding(s) in Company
12th Nov 20147:00 amRNSCompletion of Placement
11th Nov 20147:06 amRNSHolding(s) in Company
5th Nov 20147:00 amRNSNotice of AGM and Annual Report
4th Nov 20147:00 amRNSIncrease in Private Placement
22nd Oct 20147:00 amRNSDealings in Shares
21st Oct 20147:00 amRNSPrivate Placement to Support Accelerated Growth
14th Oct 20147:00 amRNSPublication of Annual Report
26th Sep 20147:00 amRNSDirector Share Transfer
19th Sep 20147:00 amRNSGrant of Options and Movement of Treasury Shares
10th Sep 20147:00 amRNSFinal Results
3rd Sep 20147:00 amRNSAnnouncement of Prelims & Investor Conference Call
4th Jul 20147:00 amRNSOptions Granted To and Exercised by Directors
2nd Jul 20147:04 amRNSPRECLOSE PERIOD UPDATE 2H FY 2014
17th Jun 20147:00 amRNSManagement Changes
10th Jun 20147:50 amRNSHolding(s) in Company
8th May 20147:00 amRNSDealings in Shares
2nd May 20147:00 amRNSExercise of Options
25th Apr 20147:00 amRNSDealings in Shares
8th Apr 20147:00 amRNSDirector's Shareholding
28th Mar 20147:00 amRNSExercise of Options
25th Mar 20147:50 amRNSHolding(s) in Company
19th Mar 20147:00 amRNSInterim Results
18th Mar 20147:00 amRNSBoard Change
10th Mar 20147:00 amRNSAnnouncement of Interim Results and Investor Call
10th Jan 20147:00 amRNSOptions Granted To and Exercised by Directors
6th Jan 20147:00 amRNSTrading Update
30th Dec 20137:00 amRNSFDA GRAS "No Objection" for New Rebaudioside M
3rd Dec 20137:00 amRNSResult of AGM
28th Nov 20137:45 amRNSHolding(s) in Company
14th Nov 20137:00 amRNSDealings in Shares
6th Nov 20137:00 amRNSNotice of AGM and Annual Report
8th Oct 20137:00 amRNSLTIP Options Awarded - Options Issued to Directors
16th Sep 20137:00 amRNSFinal Results
3rd Sep 20137:00 amRNSAppointment of Broker and New Financing Facility
2nd Sep 20137:00 amRNSAnnouncement of Prelims & Investor Conference Call
19th Jul 20138:13 amRNSHolding(s) in Company
11th Jul 20137:00 amRNSChange of Brokers
9th Jul 20137:00 amRNSFDA GRAS "No Objection" for New Rebaudioside D

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.